These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28769571)

  • 1. Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis.
    Dai C; Wang M; Lu J; Dai Z; Lin S; Yang P; Tian T; Liu X; Min W; Dai Z
    Onco Targets Ther; 2017; 10():3625-3634. PubMed ID: 28769571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Values of Programmed Cell Death-Ligand 1 Expression for Prognosis, Clinicopathological Factors, and Response to Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Inhibitors in Patients With Gynecological Cancers: A Meta-Analysis.
    Zhang C; Yang Q
    Front Oncol; 2020; 10():572203. PubMed ID: 33634012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis.
    Wang Q; Liu F; Liu L
    Medicine (Baltimore); 2017 May; 96(18):e6369. PubMed ID: 28471952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis.
    Zhu L; Sun J; Wang L; Li Z; Wang L; Li Z
    Front Pharmacol; 2019; 10():962. PubMed ID: 31616289
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinicopathologic Significance and Prognostic Value of Programmed Cell Death Ligand 1 (PD-L1) in Patients With Hepatocellular Carcinoma: A Meta-Analysis.
    Li JH; Ma WJ; Wang GG; Jiang X; Chen X; Wu L; Liu ZS; Zeng XT; Zhou FL; Yuan YF
    Front Immunol; 2018; 9():2077. PubMed ID: 30254644
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients.
    Gu X; Gao XS; Xiong W; Guo W; Han L; Bai Y; Peng C; Cui M; Xie M
    Onco Targets Ther; 2016; 9():4805-13. PubMed ID: 27536144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
    Yang WF; Wong MCM; Thomson PJ; Li KY; Su YX
    Oral Oncol; 2018 Nov; 86():81-90. PubMed ID: 30409325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis.
    Yang L; Xue R; Pan C
    Onco Targets Ther; 2019; 12():3671-3682. PubMed ID: 31190869
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic Role of Programmed Death Ligand-1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis.
    Li X; Li M; Lian Z; Zhu H; Kong L; Wang P; Yu J
    Target Oncol; 2016 Dec; 11(6):753-761. PubMed ID: 27422273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and clinicopathological utility of PD-L2 expression in patients with digestive system cancers: A meta-analysis.
    Lin X; Lin K; Lin C; Wang J; Tang Y
    Int Immunopharmacol; 2020 Nov; 88():106946. PubMed ID: 33182023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological and prognostic value of PD-L1 in urothelial carcinoma: a meta-analysis.
    Wen Y; Chen Y; Duan X; Zhu W; Cai C; Deng T; Zeng G
    Clin Exp Med; 2019 Nov; 19(4):407-416. PubMed ID: 31407099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of PD-L1 expression and NLR as prognostic marker in patients with surgically resected non-small cell lung cancer.
    Wang X; Cao L; Li S; Wang F; Huang D; Jiang R
    J Cancer; 2019; 10(26):6703-6710. PubMed ID: 31777599
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of PD-L1 expression in pancreatic cancer: evidence from an updated meta-analysis.
    Liu C; Fan L; Wu Q; Shi Y; Sun X
    Pol J Pathol; 2023; 74(3):151-160. PubMed ID: 37955534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of miR17-92 family in patients with digestive system cancers: a systematic review and meta-analysis.
    Zhang X; Zhang S; He Q; Gao X; Yang L; Xu P; Zhao R; Wang Q; Zhang L; Zhao P
    Cancer Manag Res; 2019; 11():1043-1058. PubMed ID: 30774432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of programmed cell death ligand-1 expression in the tumor-infiltrating immune cells of patients with lung cancer: A meta-analysis.
    Berele BA; Yang G; Wu T
    Mol Clin Oncol; 2021 Aug; 15(2):167. PubMed ID: 34194745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of UCA1 for predicting clinical outcome in patients with digestive system malignancies.
    Liu FT; Dong Q; Gao H; Zhu ZM
    Oncotarget; 2017 Jun; 8(25):40620-40632. PubMed ID: 28380443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Programmed Cell Death Ligand-1 Expression in Nasopharyngeal Carcinoma: A Meta-Analysis of 1,315 Patients.
    Liu X; Shan C; Song Y; Du J
    Front Oncol; 2019; 9():1111. PubMed ID: 31709181
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between raf kinase inhibitor protein loss and prognosis in cancers of the digestive system: a meta-analysis.
    Yu M; Wang Q; Ding JW; Yang Z; Xie C; Lu NH
    Cancer Biomark; 2014; 14(5):389-400. PubMed ID: 25171481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of PD-L1 expression in patients with gastric cancer in East Asia: a meta-analysis.
    Liu YX; Wang XS; Wang YF; Hu XC; Yan JQ; Zhang YL; Wang W; Yang RJ; Feng YY; Gao SG; Feng XS
    Onco Targets Ther; 2016; 9():2649-54. PubMed ID: 27226727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis.
    Xu G; Sun L; Li Y; Xie F; Zhou X; Yang H; Du S; Xu H; Mao Y
    Front Oncol; 2019; 9():897. PubMed ID: 31620360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.